Trial NCT03201250

View at ClinicalTrials.gov 
Org. Study IDs: 0434-17-FB

Last trial update was posted on 2023-09-08

MeSH Interventions

Dexamethasone

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions

Refractory Multiple Myeloma Relapsed/Refractory Multiple Myeloma

Stopping Reasons

Phase I response to treatment was not as expected and the myeloma field in treatment has changed since initiating the study, so investigators felt the study should not be pursued into Phase II.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID